U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148414) titled 'A Study of SPY072 in Rheumatic Disease' on Aug. 21.
Brief Summary: This is a multi-center, double-blind, placebo-controlled, Phase 2, proof-of-concept basket study with the goal of assessing the efficacy and safety of SPY072 compared to placebo in adults (aged >=18 years) with rheumatic disease (RD).
Study Start Date: Aug. 21
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis
Psoriatic Arthritis
Axial Spondyloarthritis
Rheumatic Diseases
Rheumatic Joint Disease
PsA (Psoriatic Arthritis)
AxSpA
Rheumatologic Disease
Intervention:
DRUG: SPY002-072
Experimental
DRUG: Placebo
Matching Placebo
Recruitment Status: RECRUIT...